Chemerin is a novel adipokine associated with obesity and metabolic syndrome K Bozaoglu, K Bolton, J McMillan, P Zimmet, J Jowett, G Collier, K Walder, ... Endocrinology 148 (10), 4687-4694, 2007 | 1260 | 2007 |
Epigenome-wide association of DNA methylation markers in peripheral blood from Indian Asians and Europeans with incident type 2 diabetes: a nested case-control study JC Chambers, M Loh, B Lehne, A Drong, J Kriebel, V Motta, S Wahl, ... The lancet Diabetes & endocrinology 3 (7), 526-534, 2015 | 482 | 2015 |
Chemerin is associated with metabolic syndrome phenotypes in a Mexican-American population K Bozaoglu, D Segal, KA Shields, N Cummings, JE Curran, AG Comuzzie, ... The journal of clinical endocrinology & metabolism 94 (8), 3085-3088, 2009 | 377 | 2009 |
Chemerin, a novel adipokine in the regulation of angiogenesis K Bozaoglu, JE Curran, CJ Stocker, MS Zaibi, D Segal, ... The Journal of Clinical Endocrinology & Metabolism 95 (5), 2476-2485, 2010 | 300 | 2010 |
Impact of DISC1 variation on neuroanatomical and neurocognitive phenotypes MA Carless, DC Glahn, MP Johnson, JE Curran, K Bozaoglu, TD Dyer, ... Molecular psychiatry 16 (11), 1096-1104, 2011 | 102 | 2011 |
Elevated chemerin levels in Pakistani men: an interrelation with metabolic syndrome phenotypes SS Fatima, K Bozaoglu, R Rehman, F Alam, AS Memon PloS one 8 (2), e57113, 2013 | 74 | 2013 |
The emerging role of Rab GTPases in the pathogenesis of Parkinson's disease Y Gao, GR Wilson, SEM Stephenson, K Bozaoglu, MJ Farrer, PJ Lockhart Movement Disorders 33 (2), 196-207, 2018 | 56 | 2018 |
N-acetylcysteine (NAC) in schizophrenia resistant to clozapine: a double blind randomised placebo controlled trial targeting negative symptoms SL Rossell, PS Francis, C Galletly, A Harris, D Siskind, M Berk, ... BMC psychiatry 16, 1-9, 2016 | 56 | 2016 |
The influence of the glutamatergic system on cognition in schizophrenia: a systematic review EHX Thomas, K Bozaoglu, SL Rossell, C Gurvich Neuroscience & Biobehavioral Reviews 77, 369-387, 2017 | 50 | 2017 |
Do schizotypy dimensions reflect the symptoms of schizophrenia? EHX Thomas, SL Rossell, EJ Tan, E Neill, TE Van Rheenen, ... Australian & New Zealand Journal of Psychiatry 53 (3), 236-247, 2019 | 45 | 2019 |
The structure of vanin 1: a key enzyme linking metabolic disease and inflammation YL Boersma, J Newman, TE Adams, N Cowieson, G Krippner, K Bozaoglu, ... Acta Crystallographica Section D: Biological Crystallography 70 (12), 3320-3329, 2014 | 43 | 2014 |
Generation of iPSC lines from peripheral blood mononuclear cells from 5 healthy adults K Vlahos, K Sourris, R Mayberry, P McDonald, FF Bruveris, JV Schiesser, ... Stem Cell Research 34, 101380, 2019 | 37 | 2019 |
Genetic variation in SH3-domain GRB2-like (endophilin)-interacting protein 1 has a major impact on fat mass N Cummings, KA Shields, JE Curran, K Bozaoglu, J Trevaskis, ... International Journal of Obesity 36 (2), 201-206, 2012 | 32 | 2012 |
TRAK2, a novel regulator of ABCA1 expression, cholesterol efflux and HDL biogenesis NJ Lake, RL Taylor, H Trahair, KN Harikrishnan, JE Curran, M Almeida, ... European Heart Journal 38 (48), 3579-3587, 2017 | 31 | 2017 |
DNA methylation patterns from peripheral blood separate coronary artery disease patients with and without heart failure CR Bain, M Ziemann, A Kaspi, AW Khan, R Taylor, H Trahair, I Khurana, ... ESC heart failure 7 (5), 2468-2478, 2020 | 30 | 2020 |
Association of genetic variation within UBL5 with phenotypes of metabolic syndrome K Bozaoglu, JE Curran, KS Elliott, KR Walder, TD Dyer, DL Rainwater, ... Human Biology 78 (2), 147-159, 2006 | 26 | 2006 |
Acute effects of active breaks during prolonged sitting on subcutaneous adipose tissue gene expression: an ancillary analysis of a randomised controlled trial MS Grace, MF Formosa, K Bozaoglu, A Bergouignan, M Brozynska, ... Scientific Reports 9 (1), 3847, 2019 | 25 | 2019 |
Investigation of genetic variation underlying central obesity amongst South Asians WR Scott, W Zhang, M Loh, ST Tan, B Lehne, U Afzal, J Peralta, ... PloS one 11 (5), e0155478, 2016 | 24 | 2016 |
Plasma levels of soluble interleukin 1 receptor accessory protein are reduced in obesity K Bozaoglu, C Attard, H Kulkarni, N Cummings, VP Diego, MA Carless, ... The Journal of Clinical Endocrinology & Metabolism 99 (9), 3435-3443, 2014 | 22 | 2014 |
N-Acetylcysteine (NAC) in Schizophrenia Resistant to Clozapine: A Double-Blind, Randomized, Placebo-Controlled Trial Targeting Negative Symptoms E Neill, SL Rossell, C Yolland, D Meyer, C Galletly, A Harris, D Siskind, ... Schizophrenia Bulletin 48 (6), 1263-1272, 2022 | 19 | 2022 |